This inventor holds 1 USPTO granted patent. Top assignee: Ortho Diagnostics, Inc.. Active years: 1980.
Company Filing History:
Years Active: 1980
Title: Kurt Myrmel: Innovator in Fibrin Detection
Introduction
Kurt Myrmel is a notable inventor based in Somerville, NJ (US). He has made significant contributions to the field of medical diagnostics, particularly in the detection of fibrin monomers. His innovative approach has the potential to enhance the accuracy of blood analysis.
Latest Patents
Kurt Myrmel holds a patent titled "Detection of fibrin monomer and composition therefor." This patent describes a quantitative method and composition for precipitating fibrin monomers from plasma in the presence of fibrinogen. The method ensures that only a small amount, if any, of fibrinogen is precipitated. The buffered precipitating agent provided has a pH in the range of 6.5 ± 0.5, utilizing buffers such as 2-(N-morpholino)ethanesulfonic acid, sodium phosphate, histidine, maleic acid, and imidazole. The analysis of the amount of fibrin present can be conducted by measuring the absorbance at 282 nanometers using a basic urea solution containing sodium hydroxide.
Career Highlights
Kurt Myrmel is associated with Ortho Diagnostics, Inc., where he applies his expertise in medical diagnostics. His work focuses on improving methods for analyzing blood components, which is crucial for various medical applications.
Collaborations
Kurt collaborates with talented individuals such as D Joe Baughman and Ann Lytwyn. Their combined efforts contribute to advancements in the field of diagnostics.
Conclusion
Kurt Myrmel's innovative work in fibrin detection exemplifies the impact of dedicated inventors in the medical field. His contributions are paving the way for improved diagnostic methods that can benefit healthcare professionals and patients alike.